Home / Intelligence / White Papers / Tethering to Reality: Integrating HCP-level Real-World Data into Brand Share Estimation
Share estimates from demand studies in primary market research (PMR) are a critical input for any forecast—their accuracy is paramount for successful brand planning.
Successful prediction is often elusive—from 2020 through 2022, only one in ten products had actual performance that aligned with forecasted expectations.*
Recognizing this challenge, Trinity experts developed a method that significantly improves prediction of future prescribing behavior in demand studies.
It is often difficult for Healthcare Professionals (HCPs) to offer precise share estimates when responding to surveys in PMR. HCPs typically do not think about their prescribing behavior holistically in their daily practice—they may have recall bias, recency bias towards newer brands, or some combination of factors. Some of these estimation errors may be overcome by using real or simulated patient chart-based methods (e.g., patient simulation, chart abstraction) that capture clinical decision-making rather than methods based on an aggregate recall of their prescribing behavior (i.e., percentage-based share estimates from a share allocation exercise). Still, there are several factors that physicians may not be able to appropriately consider when thinking about a future market being evaluated in the study, such as patients actually filling or refilling the script, insurance coverage, formulary restrictions, sales and marketing efforts by the manufacturer, etc.
Complete the form below to access the full white paper
Insights & Analytics in Life Sciences: How to Embrace a Future with Generative AI
First, A Few Potentially Unsettling Truths Broader Context & Concerns From our industry benchmarking research, we know that GenAI is seen as the biggest trend for 2024 in pharma Insights & Analytics (I&A). There is massive pressure from stakeholders, senior management and even board members to do something with GenAI—and constant questions about creating and […]
Key Takeaways and Learnings from ISPOR Europe 2023
Trinity Life Sciences recently attended the ISPOR Europe 2023 conference in Copenhagen, Denmark. The main theme of the conference was “HEOR at the Nexus of Policy and Science,” and the event featured unique discussions and workshops across different stakeholders from both academics and the life sciences industry, including manufacturers, regulatory leaders and health economists, to […]
Intellus Worldwide Institute 2023: Key Topics and Themes
Recently Trinity Life Sciences’ team members had the opportunity to attend the Intellus Worldwide Institute in Boston. The institute featured interactive discussions about topics impacting health insights and analytics, including the evolving payer landscape, increasing importance of patient segmentation and growing role of AI in healthcare. Evolving Payer Research Landscape Discussions about the payer research […]